Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
15.54
0.01 (0.07%)
At close: Jun 06, 2025, 3:59 PM
15.51
-0.19%
After-hours: Jun 06, 2025, 05:14 PM EDT
Revenue by Geography
| Period Ending | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
|---|---|---|---|---|---|---|
| India Country Revenue | 48.47B | 50.5B | 43.99B | 36.25B | 32.09B | 28.8B |
| India Country Revenue Growth | -4.01% | +14.81% | +21.33% | +12.97% | +11.40% | n/a |
| Others Countries Country Revenue | 72.83B | 67.47B | 68.96B | 60.95B | 49.58B | 40.45B |
| Others Countries Country Revenue Growth | +7.94% | -2.16% | +13.14% | +22.93% | +22.58% | n/a |
| Russia Country Revenue | 22.3B | 21.23B | 20.88B | 15.82B | 16.9B | 15.3B |
| Russia Country Revenue Growth | +5.05% | +1.67% | +32.01% | -6.41% | +10.46% | n/a |
| United States Revenue | 135.56B | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.12B | 23.01B | 22.69B | 20.48B | 20.23B | 18.8B | 17.7B | 28.29B | 17.98B | 16.56B | 15.49B | 15.67B | 15.41B | 15.95B | 15.04B | 14.28B | 14.39B | 13.11B | 12.79B | 12.18B | 12.67B | 16.78B | 12.06B | 12.38B | 12.04B | 12.37B | 12.11B | 12.07B | 12.05B | 11.03B | 11.76B | 10.97B | 11.34B | 11.77B | 12.28B | 11.63B | 12.04B | 11.06B | 10.97B | 10.08B |
| Selling, General, and Administrative Revenue Growth | +4.82% | +1.39% | +10.82% | +1.23% | +7.62% | +6.17% | -37.43% | +57.34% | +8.58% | +6.89% | -1.15% | +1.71% | -3.39% | +6.02% | +5.36% | -0.75% | +9.77% | +2.51% | +5.00% | -3.89% | -24.48% | +39.06% | -2.51% | +2.82% | -2.72% | +2.20% | +0.32% | +0.16% | +9.21% | -6.21% | +7.20% | -3.24% | -3.68% | -4.15% | +5.61% | -3.38% | +8.87% | +0.77% | +8.84% | n/a |
| Research and Development Revenue | 6.66B | 7.27B | 6.19B | 6.88B | 5.57B | 5.45B | 4.98B | 5.37B | 4.82B | 4.87B | 4.33B | 4.33B | 4.16B | 4.46B | 4.53B | 4.09B | 4.11B | 4.36B | 3.98B | 4.19B | 3.95B | 3.66B | 3.61B | 3.66B | 3.67B | 4.12B | 4.16B | 4.35B | 4.67B | 4.17B | 5.08B | 4.58B | 4.96B | 5.21B | 4.8B | 4.88B | 4.09B | 4.47B | 4.39B | 5.14B |
| Research and Development Revenue Growth | -8.43% | +17.41% | -9.95% | +23.58% | +2.17% | +9.29% | -7.12% | +11.30% | -0.99% | +12.58% | -0.02% | +4.02% | -6.81% | -1.57% | +10.75% | -0.34% | -5.76% | +9.52% | -5.01% | +6.10% | +7.84% | +1.47% | -1.45% | -0.16% | -10.97% | -0.89% | -4.39% | -6.84% | +11.78% | -17.73% | +10.83% | -7.61% | -4.95% | +8.58% | -1.58% | +19.15% | -8.45% | +1.96% | -14.72% | n/a |